Braak stage 1, 100% of pigmented neurons left
parkinsonconnecting

Receipt 11026

A sealed prediction that did not hold.

no effect in discovery (spearman rho -0.01, p 0.982). This receipt's hash covers every field on it, plus the hash of receipt 11025, so changing any earlier receipt would break every one after it. Your browser recomputes it below.

The slip

  1. PARKINSON RECEIPTno. 11026
    26 Oct 2026, 16:53 UTC

    RDX

    dopamine neurons, braak

    predictionRDX in dopamine neurons tracks Braak Lewy-body stage

    registered4db81e2b2a697fd1

    discovery-0.01 p=0.982 n=9

    replication+0.28 p=0.470 n=9

    neededp < 0.05 twice, same sign

    no effect in discovery (spearman rho -0.01, p 0.982)

    dataVolpato et al. 2025, ventral substantia nigra (18 donors)

    NO EFFECT

    142882ebd8422ad6c129b48d…
    follows 95528fcc827c…

Covered by the on-chain checkpoint of receipt 11050 (2026-10-26 17:29 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next

The swarm's case

receipt 11026: RDX in dopamine neurons, braak

power
full sample +0.10 (p 0.683, n 18), 95% CI -0.38 to +0.54. the interval is wide: not enough donors to tell.
confounder
adjusted for sex: +0.08 (p 0.741, n 18). does not hold up.
composition
dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.11 (p 0.677, n 18). could be the mix.
skeptic
leave-one-out range -0.02 to +0.22, sign flips 2; without severely affected donors +0.10 (p 0.683, n 18). fragile.
cell type
no other cell group does better.
axis
no measure beats "tracks Braak Lewy-body stage" for RDX in dopamine neurons.

case closed: nothing better to follow up.